Evolution of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavir.
about
Effect of a protease inhibitor-induced genetic bottleneck on human immunodeficiency virus type 1 env gene populations.Generation of infectious feline immunodeficiency virus (FIV) encoding FIV/human immunodeficiency virus chimeric protease.Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response.Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.Single genome sequencing of HIV-1 gag and protease resistance mutations at virologic failure during the OK04 trial of simplified versus standard maintenance therapyAccurate sampling and deep sequencing of the HIV-1 protease gene using a Primer IDSelection of drug-resistant feline immunodeficiency virus (FIV) encoding FIV/HIV chimeric protease in the presence of HIV-specific protease inhibitorsInferring viral population structures using heteroduplex mobility and DNA sequence analysesA phylogenetic and Markov model approach for the reconstruction of mutational pathways of drug resistance.Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS.Human Immunodeficiency Virus Gag and protease: partners in resistance.Fitness landscape of human immunodeficiency virus type 1 protease quasispecies.
P2860
Q33912028-FC098CCC-58F5-437F-BA5F-F96CC82D3848Q33990752-9D648EC4-F7D5-4663-85B9-1199689DA6C8Q34012585-015FC622-11F3-404B-AE5F-71B56648FE6BQ35024024-8B68B623-5BF0-4133-9846-68EC4E06C05BQ35158051-1C0943F0-39D6-404D-9A2C-C76A568890D9Q35647691-931C29EA-4DD3-41BC-9B46-F667020710F8Q37036823-01DC6801-5E1E-49A5-BD54-C7796B2676BBQ37302765-3D546571-5ACA-42A2-8B97-6982593D0589Q37364205-32A57E2D-177F-4179-9005-99075F0573B5Q37395149-585BCA8B-131F-4D54-B695-F624FE796A9BQ38032330-52507A85-E4DC-4F4E-85E7-0751EDCC22DAQ42089613-E9B647E9-F148-4BE2-B96F-C9DC76DEE122
P2860
Evolution of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavir.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Evolution of human immunodefic ...... protease inhibitor ritonavir.
@en
Evolution of human immunodefic ...... protease inhibitor ritonavir.
@nl
type
label
Evolution of human immunodefic ...... protease inhibitor ritonavir.
@en
Evolution of human immunodefic ...... protease inhibitor ritonavir.
@nl
prefLabel
Evolution of human immunodefic ...... protease inhibitor ritonavir.
@en
Evolution of human immunodefic ...... protease inhibitor ritonavir.
@nl
P2093
P2860
P1433
P1476
Evolution of human immunodefic ...... protease inhibitor ritonavir.
@en
P2093
Janera Harris
Neil Parkin
Terri Watkins
Wolfgang Resch
P2860
P304
10638-10649
P356
10.1128/JVI.79.16.10638-10649.2005
P407
P577
2005-08-01T00:00:00Z